* Rockwell Medical Inc RMTI.OQ RMTI.O is expected
to show a
rise in quarterly revenue when it reports results on November
11 for the period ending September 30 2024
* The Wixom Michigan-based company is expected to report a
11.5% increase in revenue to $26.499 million from $23.77 million
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Rockwell Medical Inc is
for
earnings of 1 cent per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Rockwell
Medical
Inc is $7.50, above its last closing price of $4.19.
This summary was machine generated November 8 at 15:44 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)